Ubs Fund Management (luxembourg) S.a. - Net Worth and Insider Trading

Ubs Fund Management (luxembourg) S.a. Net Worth

The estimated net worth of Ubs Fund Management (luxembourg) S.a. is at least $39 Million dollars as of 2025-06-08. Ubs Fund Management (luxembourg) S.a. is the 2102 Investment manager of MicroTech Medical (Hangzhou) Co Ltd and owns about 6,305,600 shares of MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) stock worth over $39 Million. Details can be seen in Ubs Fund Management (luxembourg) S.a.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ubs Fund Management (luxembourg) S.a. has not made any transactions after 2021-10-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Ubs Fund Management (luxembourg) S.a.

Ubs Fund Management (luxembourg) S.a. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ubs Fund Management (luxembourg) S.a. owns 1 companies in total, including MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) .

Click here to see the complete history of Ubs Fund Management (luxembourg) S.a.’s form 4 insider trades.

Insider Ownership Summary of Ubs Fund Management (luxembourg) S.a.

Ticker	Company	Transaction Date	Type of Owner
HKSE:02235	MicroTech Medical (Hangzhou) Co Ltd	2021-10-19	2102 Investment manager

Ubs Fund Management (luxembourg) S.a. Latest Holdings Summary

Ubs Fund Management (luxembourg) S.a. currently owns a total of 1 stock. Ubs Fund Management (luxembourg) S.a. owns 6,305,600 shares of MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) as of October 19, 2021, with a value of $39 Million.

Latest Holdings of Ubs Fund Management (luxembourg) S.a.

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02235	MicroTech Medical (Hangzhou) Co Ltd	2021-10-19	6,305,600	6.20	39,094,720

Holding Weightings of Ubs Fund Management (luxembourg) S.a.

Ubs Fund Management (luxembourg) S.a. Form 4 Trading Tracker

According to the SEC Form 4 filings, Ubs Fund Management (luxembourg) S.a. has made a total of 1 transactions in MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in MicroTech Medical (Hangzhou) Co Ltd is the sale of 6,305,600 shares on October 19, 2021, which brought Ubs Fund Management (luxembourg) S.a. around $194 Million.

Insider Trading History of Ubs Fund Management (luxembourg) S.a.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ubs Fund Management (luxembourg) S.a. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ubs Fund Management (luxembourg) S.a. Ownership Network

Ownership Network List of Ubs Fund Management (luxembourg) S.a.

No Data

Ownership Network Relation of Ubs Fund Management (luxembourg) S.a.

Ubs Fund Management (luxembourg) S.a. Owned Company Details

What does MicroTech Medical (Hangzhou) Co Ltd do?

Who are the key executives at MicroTech Medical (Hangzhou) Co Ltd?

Ubs Fund Management (luxembourg) S.a. is the 2102 Investment manager of MicroTech Medical (Hangzhou) Co Ltd. Other key executives at MicroTech Medical (Hangzhou) Co Ltd include 2101 Beneficial owner OrbiMed Asia Partners V, L.P. , 2201 Interest of corporation controlled by you OrbiMed Asia GP V, L.P. , and 2201 Interest of corporation controlled by you OrbiMed Advisors V Limited .

MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) Insider Trades Summary

Over the past 18 months, Ubs Fund Management (luxembourg) S.a. made no insider transaction in MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235). Other recent insider transactions involving MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) include a net purchase of 4,594,400 shares made by OrbiMed Asia GP V, L.P. , a net purchase of 4,594,400 shares made by OrbiMed Advisors V Limited , and a net purchase of 4,594,400 shares made by OrbiMed Asia Partners V, L.P. .

In summary, during the past 3 months, insiders sold 0 shares of MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) were sold and 34,783,200 shares were bought by its insiders, resulting in a net purchase of 34,783,200 shares.

MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235)'s detailed insider trading history can be found in Insider Trading Tracker table.

MicroTech Medical (Hangzhou) Co Ltd Insider Transactions

No Available Data

Ubs Fund Management (luxembourg) S.a. Mailing Address

Above is the net worth, insider trading, and ownership report for Ubs Fund Management (luxembourg) S.a.. Currently GuruFocus does not have mailing address information for Ubs Fund Management (luxembourg) S.a..

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.